Psychiatrist and Fellow of the American Psychiatric Association
Rodrigo Muñoz, M.D., is the 127th president of the American Psychiatric Association. He currently works at the University of California San Diego as a Clinical Professor of Psychiatry and has his own private practice in San Diego, California. Dr. Muñoz actively participates in programs working to better healthcare for the indigent, the homeless, and those who suffer from chronic mental illness.
Born and raised in Colombia, Dr. Muñoz obtained his medical degree at the University of Cauca in Popayan. After completing his first residency at the Mental Hospital in Medellin, Colombia, Dr. Muñoz moved to the states where he completed two more rounds of residency, one at Fairfield Hills Hospital in Newton, Connecticut, and another at Washington University in St. Louis, Missouri. Since his time at Washington University, Dr. Muñoz has worked for a number of hospitals, healthcare centers, and universities as a physician and teacher.
The medical community has heavily thanked Dr. Muñoz for his commitment to mental healthcare. A few granted honors include the 1990 Certificate of Recognition for Outstanding Scientific Contributions from the Physicians Association of Clinics, Hospitals, and Annex (PACHA), the 1997 Physician of the Year Award from the San Diego County Medical Society, and the 2000 Simon Bolivar Award from The Committee of Hispanic Psychiatrists in the APA.
Grants and Funding: We proudly support the research and programs of 501(c)(3) non-profit organizations and institutions such as: the Anxiety Disorders program of the Jane & Terry Semel Institute for Neuroscience & Human Behavior at the University of California, Los Angeles; the Pacific Institute of Medical Research; the International Foundation for Research and Education on Depression (iFred); and SchoolsForHope.org, an iFred educational project. Working with these partners enables Anxiety.org to extend its commitment to its mission. All the donations received, as well as 100% of Anxiety.org revenue in 2018, will be contributed to build, develop, and further the understanding, investigation, discovery, and treatment of the full spectrum of anxiety and related disorders.